Bacterial Infections (Bacterial Infection)

05/01/2015 - "Demonstration of efficacy of the antibacterial agents in animal models of bacterial infection is highly desirable. "
08/01/2008 - "This study suggests that GSPBRT-PCR is very useful for the rapid and accurate diagnosis of bacterial infection and that it can have an important impact on the current inappropriate and unnecessary use of antibiotics in the treatment of newborns."
12/01/2010 - "Efflux systems are important in determining the efficacy of antibiotics used in the treatment of bacterial infections. "
02/01/2011 - "Bacterial infection in orthopaedic surgery can be devastating, and is associated with significant morbidity and poor functional outcomes, which may be improved if high concentrations of antibiotics can be delivered locally over a prolonged period of time. "
08/01/1988 - "A significantly greater proportion (4.5%) of subsequent bacterial infections occurred in infants who received parenteral antibiotics (p = 0.01), and especially in a subgroup who received parenteral antibiotics for 5 or more days (11%, p less than 0.001). "

03/01/1991 - "Ciprofloxacin appears to be effective for preventing bacterial infections in neutropenic patients. "
12/11/1987 - "Prolonged administration of ciprofloxacin turned out to be safe and effective in preventing serious aerobic bacterial infections during the first three months after BMT."
09/01/2008 - "Singh et al. from Chandigarh and New Delhi for their original paper: "Efficacy of indigenously developed single vial kit preparation of (99m)Tc-ciprofloxacin in the detection of bacterial infection-An Indian experience" and to Dr. A. "
01/01/2003 - "[Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment]."
04/01/1989 - "Efficacy of ciprofloxacin in the treatment of various bacterial infections."

01/01/2010 - "Although the exact physiologic function of procalcitonin has not been determined, the consistent response and rapid rise of this protein in the setting of severe bacterial infection make procalcitonin a very useful biomarker for invasive bacterial disease. "
01/01/2010 - "Procalcitonin is superior to other commonly used markers in its specificity for bacterial infection (allowing alternative diagnoses to be excluded), as an indicator of disease severity and risk of death, and mainly as a guide to the necessity for antibiotic therapy. "
01/01/2014 - "Procalcitonin (PCT) is helpful for diagnosing bacterial infections. "
04/13/2004 - "We hypothesized that serum procalcitonin, a marker of systemic bacterial infection, might be helpful in its diagnosis. "
11/01/2015 - "The aim of this study was to evaluate the use of procalcitonin in the assessment of bacteraemia in patients in the emergency department, both alone and in conjunction with existing inflammatory markers of bacterial infection. "

10/01/1983 - "Ceftriaxone given in a 24-hourly regimen is convenient and highly effective in serious bacterial infections in children and is without significant toxicity."
05/01/1997 - "Once daily infusion of ceftriaxone therefore seems to be effective in the treatment of severe bacterial infections in Chinese patients."
11/01/1984 - "Ceftriaxone (Ro 13-9904, CTRX) was evaluated in 20 children with a suspicion of bacterial infections, 18 were shown to be effective (efficacy rate, 90%). "
11/01/1996 - "Ceftriaxone may be useful in the treatment of bacterial infections in horses. "
03/01/1982 - "Our findings suggest that ceftriaxone is a safe and effective antibiotic for therapy of serious bacterial infections."

04/01/2014 - "Polysaccharide based-vaccines have been successful in providing protection in adults from bacterial infections, however they are not as effective in infants or young children. "
10/01/2014 - "These results provide new insights into the role of systemic C3 in regulating contraction following intracellular bacterial infection and may help to develop vaccines that are more effective. "
09/01/1985 - "Since vaccines effective against the likely major pathogens in the youngest children are not available, the acute respiratory infection control programs designed by the World Health Organization are based on simple schemes to classify illness according to severity and to treat bacterial infections early, thus preventing severe complications. "
10/26/2004 - "The lipidated vaccines, but not the nonlipidated vaccines, were able to mediate protection against viral or bacterial infection and mediate prophylactic and therapeutic anticancer activity. "
10/29/2010 - "Despite the impressive success of currently approved adjuvants for generating immunity to viral and bacterial infections, there remains a need for improved adjuvants that enhance protective antibody responses, especially in populations that respond poorly to current vaccines. "

01/01/1987 - "It is highly immunogenic in mice and most murine strains have circulating anti-PC antibodies which are known to confer protection against certain bacterial infections. "
01/01/2015 - "These antibodies are thought to provide a first line of defense against bacterial infections and play a major role in the clearance of apoptotic cells. "
01/01/1998 - "These results suggest that antibodies in low-heat skim milk, which still have reactivity to exogenous or indigenous bacteria, may contribute to the protective effects against bacterial infection."
07/01/2013 - "Maternal antibodies give neonates some protection against bacterial infection. "
01/01/2005 - "Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies."

06/15/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the eyelids or conjunctiva, or both. "
01/01/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the lids and/or conjunctiva. "
05/01/1992 - "The aim of the study has been to assess if intermittent treatment with norfloxacin could be able to maintain selective intestinal decontamination in cirrhotic patients in order to prevent bacterial infections. "
04/01/2013 - "Norfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. "
03/16/2011 - "Synthesis and biodistribution of a novel (⁹⁹m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging."

01/01/2002 - "Levofloxacin therefore offers a unique combination of documented efficacy and tolerability, and provides an important option for the treatment of bacterial infections."
12/01/2012 - "This post-marketing surveillance of levofloxacin, conducted over 4 years, confirms the safety and efficacy of levofloxacin in regular clinical use and highlights that levofloxacin is a promising treatment for a variety of external ocular bacterial infections."
06/01/2009 - "Intravenous levofloxacin with a dose of 500 mg once a day is effective and safe in treating bacterial infections with low adverse reactions."
12/01/2012 - "This study was designed to investigate the safety and efficacy of levofloxacin 0.5% ophthalmic solution in patients who received treatment for external ocular bacterial infections in regular clinical practice. "
06/01/2009 - "[The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial]."

12/24/1992 - "The time to a first bacterial infection was significantly greater for those assigned to trimethoprim-sulfamethoxazole (P = 0.017). "
04/01/1990 - "Several trials showed that cotrimoxazole was effective for the prevention of bacterial infection: thus, this antimicrobial can be used as long-term and continuous prophylaxia. "
08/01/1991 - "Prophylactic co-trimoxazole was effective in reducing the frequency of bacterial infections. "
06/01/1998 - "In conclusion, the results of the study suggest that TMP-SMX appears to be a valuable alternative to P-S, in particular in patients with opportunistic bacterial infections."
06/01/1996 - "Bacterial infection during the 3-month study period occurred in 11 control patients but in only 2 patients assigned TMP-SMX (P = 0.004). "

07/01/2013 - "In conclusion, the investigated IVIG preparation was well tolerated and clinically beneficial in reducing the long term rate of serious bacterial infections in patients receiving concomitant treatment for malignant diseases. "
03/01/1993 - "In addition, the current studies do not establish the efficacy of IVIg for either treating or preventing neonatal bacterial infections. "
11/01/2006 - "[Efficacy of intravenous immunoglobulins in bacterial infections]."
07/01/1994 - "IVIG therapy may also reduce the mortality and incidence of bacterial infections in adults but further studies are required. "
06/01/1994 - "In patients who received placebo during the original study, the rate of serious bacterial infections was significantly lower after change to open label IVIG (estimated 15.8 fewer episodes/100 patient years; 95% confidence interval, 3.2 to 28.5; P = 0.014). "

11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy. "
11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy. "
01/08/1979 - "[Prospects for bacteriological studies and chemotherapy of bacterial infections]."
09/01/2015 - "Recently, photodynamic antimicrobial chemotherapy is attracting attention again as an alternative treatment for bacterial infections. "
01/01/2015 - "Our practice of observing pediatric oncology patients undergoing chemotherapy with CVCs who are not neutropenic does not appear to lead to increased serious adverse outcomes and avoids antibiotic exposure for >90% of patients without a bacterial infection."

05/01/2008 - "This type of catheter shows a great promise in lowering the incidence of catheter-related bacterial infections."
12/01/2015 - "A catheter-related bacterial infection was suspected. "
06/01/2015 - "Readmissions not related to poor infection control, adverse events, and catheter-related complications were similar in multidrug-resistant compared to non-multidrug-resistant bacterial infections. "
03/01/2013 - "Biofilm formation seems to be a key factor in many bacterial infections, particularly those involving prosthetic implants or urinary catheters, where Escherichia coli is frequently involved. "
03/01/2011 - "We aimed to reduce late-onset bacterial infections in infants born at 22 to 29 weeks' gestation by using collaborative quality-improvement methods to implement evidence-based catheter care. "

05/28/2014 - "To prevent post-transplant bacterial infections, proper strategies need to be established based upon center-specific data and evidence from well-controlled studies. "
01/01/2014 - "The aim of this study was to determine the frequency of pre-transplant bacterial infections within one month before LDLT and their impact on the post-transplant morbidity and mortality. "
04/01/1985 - "Two patients had bacterial infections during the period of study, and one patient experienced a short-lived readily reversible rejection of a corneal transplant. "
01/01/2016 - "The question arises whether we could prepare a graft meeting mechanical conditions of an artery immunologically inert and resistant to bacterial infection. "
11/01/2015 - "This suggests that a bovine pericardial roll graft is a suitable material for use in patients with bacterial infections. "

01/01/2012 - "Trials have shown the efficacy of antibiotic prophylaxis in reducing the incidence of bacterial infections but not in reducing mortality rates. "
06/21/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections but not in reducing mortality rates. "
01/01/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections, but not in reducing mortality rates. "
01/01/2013 - "The evidence for efficacy of antibiotic prophylaxis in reducing the mortality rates and the incidence of bacterial infections was also reported by a systematic review published by Cochrane in 2012. "
01/01/2012 - "Randomised controlled trials (RCTs) or quasi-RCTs comparing different types of antibiotic prophylaxis with placebo or no intervention, or another antibiotic, to prevent bacterial infections in afebrile neutropenic patients. "

01/01/2011 - "Both clinical and experimental studies have identified bacterial infections as a possible trigger of allograft rejection. "
12/01/2008 - "This study failed to find a higher rate of deep bacterial infection in ACL reconstructions when allograft tissue was used. "
06/01/1993 - "It appears, from this study, that rejection of the lung allograft results in alterations in BAL lymphocyte phenotypes and functions that differ from those associated with bacterial infection. "
12/01/2012 - "Vascular homograft use in a femoropopliteal rare bacterial infection bypass."
10/01/2012 - "HHV-5/6-infected patients displayed more allograft rejection episodes, coinfections, and concomitant bacterial infections, besides an higher risk for CMV disease."